Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
There are many indicators of solid data that can help us broaden measures of well-being far beyond GDP.
In a just-published op-ed, American Enterprise Institute (AEI) economist Alex Brill sets forth two options to reduce health care costs in Illinois' Medicaid system. If enacted, these efforts would be a part of a broader reform effort which is necessary to avert dramatic cuts in the future.
The recent improvement in payrolls and the unemployment rate are welcome news, but the plight of the long-term unemployed in the United States is considerable. The policies that have been executed since mid-2008 to foster an economic recovery have failed to deliver measurable results, and those most hurt by the current downturn are often the long-term unemployed.
The Medicaid drug program wasted $329 million nationwide in 2009 from states all too frequently reimbursing for a version of a drug that is more costly than another product with the exact same active ingredient, dose, form and bottle size.
Although the Schumer-Lee plan deserves credit for seeking to promote international capital flows and labor mobility, it would neither make a measurable dent in the housing sector's backlog nor fix a broken immigration system that hampers our economy's long-run prospects.
Biopharma – especially big pharma – gets all sorts of grief for being large, stodgy, and unable to innovate (or evolve); this Corey Goodman interview represents the perspective well.
Before writing off these companies entirely, however (an ignorant reaction in any case),...
The term "political science" used to mean public policy studied not just as opinion but based on empirical, documentable evidence. Today it's come to mean something darker--the subversion of science in the hands of ideologues committed to manipulating public policy to their end. This new, and disheartening use of the...
As the new Congress considers the future of foreign assistance, Daniel Yohannes, CEO of MCC, and panelists from across the political spectrum will gather to discuss whether a bipartisan consensus is emerging on aid effectiveness and assess MCC's experience in putting these best principles into practice.








